Prestige And Intas Strike International Bevacizumab Deal

US And EU Filings Planned Next Year For HD204 Proposed Avastin Biosimilar

Deal handshake global
Prestige and Intas have stuck a multi-territory deal for bevacizumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business